Sequel Med Tech made significant waves when it announced the receipt of FDA clearance for an automated insulin delivery system in March. Founded in 2023, the device developer brings significant expertise in a number of channels to the table despite its short history. Sequel Med Tech co-founder and CEO Dr. Alan Lotvin has decades of […]
Sequel Med Tech
Study backs Sequel Med Tech’s automated insulin pump that provides faster occlusion detection
A study looking at automated insulin delivery technology from Sequel Med Tech highlighted the ability to address delayed occlusion detection. According to Sequel, an insulin pump’s failure to deliver insulin in the right amount at the right time is a preventable cause of hospitalization. The company says advances in insulin delivery technology so far fail […]
FDA clears automated insulin delivery system from Sequel Med Tech
Sequel Med Tech announced today that its partner, DEKA R&D, won FDA 510(k) clearance for its automated insulin delivery (AID) system. The twist system, powered by Tidepool, directly measures the volume and flow of insulin delivered with every microdose. It offers the capability and flexibility to address each patient’s individual dosing needs. Sequel will market […]
